Author:
Bai Y,Bandara G,Ching Chan E,Maric I,Simakova O,Bandara S N,Lu W-P,Wise S C,Flynn D L,Metcalfe D D,Gilfillan A M,Wilson T M
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference33 articles.
1. Escribano L, Ocqueteau M, Almeida J, Orfao A, San Miguel JF . Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leuk Lymphoma 1998; 30: 459–466.
2. Jensen BM, Akin C, Gilfillan AM . Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders. Br J Pharmacol 2008; 154: 1572–1582.
3. Hundley TR, Gilfillan AM, Tkaczyk C, Andrade MV, Metcalfe DD, Beaven MA . Kit and FcɛR1 mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 2004; 104: 2410–2417.
4. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560–10564.
5. Horny H-P, Metcalfe DD, Bennett JM, Bain BJ, Akin C, Escribano L, Valent. P . Mastocytosis. In Swerdlow SH, Campo E, Harris NL, Jaffee ES, Pileri SA, Stein H, Thiele J, Varderman JW, (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th edn. International Agency for Research on Cancer: Lyon, France, 2008, 54–63pp.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献